Abstract:Transcription activator-like effectors (TALEs), first identified in Xanthomonas bacteria, are naturally occurring or artificially designed proteins that modulate gene transcription. These proteins recognize and bind DNA sequences based on a variable numbers of tandem repeats. Each repeat is comprised of a set of ∼ 34 conserved amino acids; within this conserved domain, there are usually two amino acids that distinguish one TALE from another. Interestingly, TALEs have revealed a simple cipher for the one-to-one recognition of proteins for DNA bases. Synthetic TALEs have been used to successfully target genes in a variety of species, including humans. Depending on the type of functional domain that is fused to the TALE of interest, these proteins can have diverse biological effects. For example, after binding DNA, TALEs fused to transcriptional activation domains can function as robust transcription factors (TALE-TFs), while fused to restriction endonucleases (TALENs) can cut DNA. Targeted genome editing, in theory, is capable of modifying any endogenous gene sequence of interest; this can be performed in cells or organisms, and may be applied to clinical gene-based therapies in the future. With current technologies, highly accurate, specific, and reliable gene editing cannot be achieved. Thus, recognition and binding mechanisms governing TALE biology are currently hot research areas. In this review, we summarize the major advances in TALE technology over the past several years with a focus on the interaction between TALEs and DNA, TALE design and construction, potential applications for this technology, and unique characteristics that make TALEs superior to zinc finger endonucleases.

Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modification

Modularly Assembled Designer TAL Effector Nucleases for Targeted Gene Knockout and Gene Replacement in Eukaryotes.

Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

A Simple and Efficient Method for Assembling TALE Protein Based on Plasmid Library.

TALE: a tale of genome editing.

ULtiMATE System for Rapid Assembly of Customized TAL Effectors

Transcription Activator‐like Effector Nucleases (talens): A Highly Efficient and Versatile Tool for Genome Editing

FairyTALE: A High-Throughput TAL Effector Synthesis Platform

A One-Step System for Convenient and Flexible Assembly of Transcription Activator-Like Effector Nucleases (TALENs)

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Advances in transcription activator-like effectors-a review

De Novo-Engineered Transcription Activator-Like Effector (TALE) Hybrid Nuclease with Novel DNA Binding Specificity Creates Double-Strand Breaks.

Advances in TALE Research

One-Day TALEN Assembly Protocol and a Dual-Tagging System for Genome Editing

Simple and Rapid Assembly of TALE Modules Based on the Degeneracy of the Codons and Trimer Repeats

[TALE Nuclease Engineering and Targeted Genome Modification].

Generate TALE/TALEN As Easily and Rapidly As Generating CRISPR

Improved USER cloning for TALE assembly and its application to base editing

A single-chain TALEN architecture for genome engineering.

Molecular “Scissors” ——TALENs Mediated Site-specific Gene Modification Technology

Chimeric TALE recombinases with programmable DNA sequence specificity